Phospholipids and cholesterol content in tumor cell plasma membranes with different sensitivity to doxorubicin

Ukrain'skyi Biokhimichnyi Zhurnal

Volumn 75, Issue 4, 2003, Pages 120-125

  Chekhun, V F ^a   Tryndiak, V P ^a   Todor, I M ^a   Mikhailenko, V M ^a   Kondrychyn, I G ^a   Dovbeshko, G I ^b   Repnytska, O P ^b   Kulik, G I ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b INSTITUTE OF PHYSICS   (Ukraine)

Author keywords

Drug resistance; Guerin's carcinoma; Phospholipids; Plasma membrane

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; CHOLESTEROL; DOXORUBICIN; MEMBRANE LIPID; PHOSPHOLIPID;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; CELL MEMBRANE; DRUG EFFECT; DRUG RESISTANCE; EXPERIMENTAL NEOPLASM; MALE; MEMBRANE FLUIDITY; METABOLISM; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL MEMBRANE; CHOLESTEROL; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; MALE; MEMBRANE FLUIDITY; MEMBRANE LIPIDS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PHOSPHOLIPIDS; RATS; RATS, WISTAR; TUMOR CELLS, CULTURED;

EID: 1542467265     PISSN: 02018470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ukrainian source
2. Thompson T. E. // Curr. Opin. Struct. Biol. 1993. 3, N 4. P. 473-493.
3. LuKer G. D., Nilsson K. R., Covey D. F., Piwnica-Worms D. // J. Biol. Chem. 1999. 274, N 11. P. 6979-6991.
4. Pajeva I. K., Wiese M., Cordes H.-P., Seydel J. K. // J. Cancer. Res. Clin. Oncol. 1996. 122, N 1. P. 27-40.
5. Ramu A., Glaubiger D., Weintraub H. //. Cancer. Treat. Rep. 1984. 68, N 4. P. 637-641.
6. Alon N., Busche R., Tiimmler B., Riordan J. K. Molecular and Cellular Biology of Multidrug resistance in tumor cells / Ed. I. B. Robinson. 1991. Plenum Press: NY. London. P. 263-276.
7. Mazzoni A., Trave F. // Oncol. Res. 1993. 5, N 2. P. 75-82.
8. Ukrainian source
9. Van Amelsvoort J. M. M., Sips H. J., Van Dam K. // Biochem. J. 1978. 174, N 3. P. 1083-1086.
10. Tyagi R. K., Azrad A., Degani H., Salomon Y. // Magn. Reson. Med. 1996. 35, N 2. 194-200.
11. Merchant T. E., de Graaf P. W., Minsky B. D. et al. // NMR Biomed. 1993. 6, N 3. 187-93.
12. Ukrainian source
13. Chekhun V. F., Solyanik G. I., Kulik G. I. et al. // J. Exp. Clin. Cancer Res. 2002. 21, N 4. P. 599-607.
14. Ukrainian source
15. Ueda K., Yoshida A., Amachi T. // Anti-Cancer Drug Design. 1999. 14, N 2. P. 115-121.
16. Shiratsuchi A., Mori T., Nakanishi Y. // J. Biochem. (Tokyo). 2002. 132, N 3. P. 381-386.
17. Poulaki V., Mitsiades C. S., Mitsiades N. // Drug Resist. Update. 2001. 4, N 4. P. 233-242.